Adult Congenital Heart Disease Center, Montreal Heart Institute, Medicine Department, Université de Montréal, Montréal, Québec, Canada.
Division of Cardiology, Department of Medicine, Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, California, USA; UCLA Cardiac Arrhythmia Center, UCLA Health System, Los Angeles, California, USA; Division of Cardiology, Department of Pediatrics, UCLA Health System, Los Angeles, California, USA.
Can J Cardiol. 2022 Jul;38(7):1048-1058. doi: 10.1016/j.cjca.2022.04.024. Epub 2022 May 17.
As a result of remarkable progress in operative techniques and cardiology care during childhood, Fontan patients continue to age and require team-based multidisciplinary expertise to manage complications encountered in adulthood. They face particular challenges in terms of altered hemodynamic stressors, cardiac and hepatic failure, and arrhythmias. Arrhythmias in Fontan patients are highly prevalent and associated with underlying anatomy, surgical technique, and postoperative sequelae. Diagnostic tools, treatments, and device strategies for arrhythmias in Fontan patients should be adapted to the specific anatomy, type of surgical repair, and clinical status. Great strides in our understanding of arrhythmia mechanisms, options and techniques to obtain access to relevant cardiac structures, and application of both old and new technologies have contributed to improving cardiac implantable electronic device (CIED) therapies for this unique population. In this state-of-the-art review, we discuss the various arrhythmias encountered in Fontan patients, their diagnosis, and options for treatment and prevention, with a focus on CIEDs. Throughout, access challenges particular to the Fontan circulation are considered. Recently developed technologies, such as the subcutaneous implantable cardioverter defibrillator, carry the potential to be transformative but require awareness of Fontan-specific issues. Moreover, new leadless pacing technology represents a promising strategy that may soon become applicable to Fontan patients with sinus-node dysfunction. CIEDs are essential tools in managing Fontan patients, but the complex clinical scenarios that arise in this patient population are among the most challenging for the electrophysiologist treating patients with congenital heart disease.
由于儿童手术技术和心脏病学护理的显著进步,Fontan 患者继续衰老,并需要团队式多学科专业知识来管理成年期遇到的并发症。他们在血流动力学应激改变、心脏和肝功能衰竭以及心律失常方面面临特殊挑战。Fontan 患者心律失常非常普遍,与潜在解剖结构、手术技术和术后后遗症有关。Fontan 患者心律失常的诊断工具、治疗方法和设备策略应适应特定的解剖结构、手术修复类型和临床状况。我们在心律失常机制、获得相关心脏结构的途径的选择和技术方面取得了巨大进展,以及新旧技术的应用,都有助于改善这一独特人群的心脏植入式电子设备(CIED)治疗。在这篇最先进的综述中,我们讨论了 Fontan 患者中遇到的各种心律失常、其诊断以及治疗和预防选择,重点是 CIED。在整个过程中,都考虑到了 Fontan 循环特有的通路挑战。最近开发的技术,如皮下植入式除颤器,具有变革性的潜力,但需要认识到 Fontan 特定的问题。此外,无导线起搏技术代表了一种很有前途的策略,可能很快就适用于窦性心动过缓的 Fontan 患者。CIED 是管理 Fontan 患者的重要工具,但在治疗先天性心脏病患者的电生理学家中,该患者群体中出现的复杂临床情况是最具挑战性的情况之一。